Hidetoshi Nakagawa
Kanazawa University Hospital(JP)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Hepatocellular Carcinoma Treatment and Prognosis, Immune Cell Function and Interaction, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity(2016)163 cited
- → A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days(2013)87 cited
- → Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib(2015)81 cited
- → Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma(2017)77 cited
- → Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma(2016)72 cited
- → Antitumor Effect after Radiofrequency Ablation of Murine Hepatoma Is Augmented by an Active Variant of CC Chemokine Ligand 3/Macrophage Inflammatory Protein-1α(2010)71 cited
- → Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection(2019)69 cited
- → Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor(2019)60 cited
- → Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy(2014)50 cited
- → Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma(2015)47 cited